GCNT2 and cancer: Lastly, further understanding of how GCNT2 and I-branched glycans regulate growth factor receptor and integrin receptor signaling may provide important insights into the design of novel cancer therapies that either directly target glycans or predict efficacy of certain therapies based on receptor glycosylation.